To get deals in your inbox each morning, sign up for our Term Sheet newsletter
Venture Capital DealsPanOptica, a Bernardsville, N.J.-based developer of ophthalmology therapies for conditions like neovascular age-related macular degeneration, has raised $45 million in Series B funding. Novo Ventures and existing backer Third Rock Ventures co-led the round, and were joined by founding investor SV Life Sciences. www.panopticapharma.com
Squarespace, a New York-based website publishing and e-commerce platform for businesses, has raised $40 million in Series MORE